Association of hospital and provider types on sickle cell disease outcomes

Pediatrics

Volumn 132, Issue 5, 2013, Pages 854-861

  Jan, Sophia ^a,b,c   Slap, Gail ^a,b   Smith Whitley, Kim ^b   Dai, Dingwei ^b   Keren, Ron ^a,b,c   Rubin, David M ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute chest syndrome; Adolescent; Anemia; Hospitals; Quality of health care; Sickle cell; Transition to adult care; Young adult

Indexed keywords

ACUTE CHEST SYNDROME; ADULT; ARTICLE; CHILD HEALTH CARE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; EXCHANGE BLOOD TRANSFUSION; FEMALE; GENERAL HOSPITAL; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEMATOLOGIST; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRIC HOSPITAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; TREATMENT OUTCOME; UNITED STATES; ADOLESCENT; ANEMIA, SICKLE CELL; FACTUAL DATABASE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; PATHOLOGY; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HOSPITALS, GENERAL; HOSPITALS, PEDIATRIC; HUMANS; MALE; PATIENT ADMISSION; PATIENT DISCHARGE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887127933     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0089     Document Type: Article

References (36)

1. Vichinsky EP, Neumayr LD, Earles AN, et al; National Acute Chest Syndrome Study Group. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000;342(25): 1855-1865. (Pubitemid 30419049)
2. Castro O, Brambilla D, Thorington B, et al The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84(2):643-649. (Pubitemid 24215969)
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644.
4. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B; Cooperative Study of Sickle Cell Disease. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood. 1997;89(5):1787-1792. (Pubitemid 27097475)
5. Reagan MM, DeBaun MR, Frei-Jones MJ. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Pediatr Blood Cancer. 2011;56 (2):262-266.
6. Crabtree EA, Mariscalco MM, Hesselgrave J, et al. Improving care for children with sickle cell disease/acute chest syndrome. Pediatrics. 2011;127(2). Available at: www.pediatrics.org/cgi/content/full/127/2/e480.
7. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447- 3452.
8. Okumura MJ, Campbell AD, Nasr SZ, Davis MM. Inpatient health care use among adult survivors of chronic childhood illnesses in the United States. Arch Pediatr Adolesc Med. 2006;160(10):1054-1060. (Pubitemid 44520636)
9. Weitzman ER, Kaci L, Quinn M, Mandl KD. Helping high-risk youth move through highrisk periods: personally controlled health records for improving social and health care transitions. J Diabetes Sci Tech. 2011; 5(1):47-54.
10. Lasky T, Ernst FR, Greenspan J, Wang S, Gonzalez L. Estimating pediatric inpatient medication use in the United States. Pharmacoepidemiol Drug Saf. 2011;20(1):76-82.
11. Stallworth JR, Jerrell JM, Tripathi A. Costeffectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. Am J Hematol. 2010;85(10):795-797.
12. Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol. 2010;85(1):24-28.
13. Lanzkron S, Carroll CP, Haywood C Jr. The burden of emergency department use for sickle-cell disease: An analysis of the national emergency department sample database. Am J Hematol. 2010;85(10):797-799.
14. Bell LE, Sawyer SM. Transition of care to adult services for pediatric solid-organ transplant recipients. Pediatr Clin North Am. 2010;57(2):593-610 [table of contents.].
15. 3M Health Information Systems, Inc., Medical Advisory Committee for NACHRI APRDRG Research Project. All Patient Refined Diagnosis Related Groups (APR-DRGs), Version 20.0. Methodology overview. Available at: www.hcup-us.ahrq.gov/db/nation/nis/APR- DRGsV20MethodologyOverviewandBibliography.pdf Accessed January 1, 2010.
16. Feudtner C, Christakis DA, Zimmerman FJ, Muldoon JH, Neff JM, Koepsell TD. Characteristics of deaths occurring in children's hospitals: implications for supportive care services. Pediatrics. 2002;109(5):887-893. (Pubitemid 34493357)
17. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: A population-based study of Washington State, 1980-1997. Pediatrics. 2000;106(suppl 1):205-209. (Pubitemid 30436857)
18. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107 (6). Available at: www.pediatrics.org/cgi/content/full/107/6/e99.
19. Wang WC, Ware RE, Miller ST, et al; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663-1672.
20. Hankins JS, Ware RE, Rogers ZR, et al Longterm hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood. 2005;106(7):2269-2275. (Pubitemid 41510795)
21. Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 2010;115(12):2354-2363.
22. Steinberg MH, Barton F, Castro O, et al Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645-1651. (Pubitemid 37430269)
23. Weiss PF, Klink AJ, Localio R, et al. Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schönlein purpura. Pediatrics. 2010;126(4):674-681.
24. Mitka M. Young adult cancer survivors face barriers to receiving primary care. JAMA. 2012;308(16):1618-1619.
25. Chua K-P, Schuster MA, McWilliams JM. Differences in health care access and utilization between adolescents and young adults with asthma. Pediatrics. 2013;131(5): 892-901.
26. Adams SH, Newacheck PW, Park MJ, Brindis CD, Irwin CE. Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30s. Pediatrics. 2007;119(5). Available at: www.pediatrics.org/cgi/content/full/ 119/5/e1033.
27. Callahan ST, Cooper WO. Continuity of health insurance coverage among young adults with disabilities. Pediatrics. 2007;119 (6):1175-1180. (Pubitemid 46871274)
28. Peter NG, Forke CM, Ginsburg KR, Schwarz DF. Transition from pediatric to adult care: internists' perspectives. Pediatrics. 2009; 123(2):417-423.
29. Okumura MJ, Heisler M, Davis MM, Cabana MD, Demonner S, Kerr EA. Comfort of general internists and general pediatricians in providing care for young adults with chronic illnesses of childhood. J Gen Intern Med. 2008;23(10):1621-1627.
30. Panepinto JA, Owens PL, Mosso AL, Steiner CA, Brousseau DC. Concentration of hospital care for acute sickle cell diseaserelated visits. Pediatr Blood Cancer. 2012; 59(4):685-689.
31. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013;60 (9):1482-1486.
32. Jan S, Slap G, Dai D, Rubin DM. Variation in surgical outcomes for adolescents and young adults with inflammatory bowel disease. Pediatrics. 2013;131(suppl 1):S81- S89.
33. McCavit TL, Lin H, Zhang S, Ahn C, Quinn CT, Flores G. Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease. Am J Hematol. 2011;86 (4):377-380.
34. Gorodeski EZ, Starling RC, Blackstone EH. Are all readmissions bad readmissions? N Engl J Med. 2010;363(3):297-298.
35. Kangovi SGD, Grande D. Hospital readmissions- not just a measure of quality. JAMA. 2011;306(16):1796-1797.
36. Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288- 1294.